DELUCA, HECTOR F.,BARYCKI, RAFAL,PLUM, LORI A.,CLAGETT-DAME, MARGARET
申请号：
CA2588417
公开号：
CA2588417C
申请日:
2005.11.18
申请国别(地区):
CA
年份:
2012
代理人:
摘要：
This invention discloses 2-methylene-18,19-dinor-vitamin D analogs, andspecifically2-methylene-18,19-dinor-1.alpha.-hydroxy-homopregnacalciferol andpharmaceutical usestherefor. This compound exhibits pronounced activity in arresting theproliferation ofundifferentiated cells and inducing their differentiation to the monocyte thusevidencing useas an anti-cancer agent and for the treatment of skin diseases such aspsoriasis as well as skinconditions such as wrinkles, slack skin, dry skin and insufficient sebumsecretion. Thiscompound also has little, if any, calcemic activity and therefore may be usedto treatautoimmune disorders or inflammatory diseases in humans as well as renalosteodystrophy.This compound may also be used for the treatment or prevention of obesity.(see formula I)
